Skip to main content

Table 1 Characteristics of study participants

From: Associations between circulating resistin concentrations and left ventricular mass are not accounted for by effects on aortic stiffness or renal dysfunction

 All Participants
(n = 647)
% Women62.8
Age (years)44.5 ± 18.2
Body mass index (kg/m2)28.9 ± 7.5
Waist circumference (cm)90.3 ± 16.3
% Overweight/obese27.0/40.7
% Central obesity42.5
% Hypertension47.4
% Treated for DM8.6
% DM or HbA1c > 6.5%14.1
% Regular smoking15.8
% Regular alcohol20.2
% Metabolic syndromea28.9/24.7/14.1/7.7/2.6
Office SBP/DBP (mm Hg)128 ± 22/83 ± 12
LV mass (LVM)(g)151 ± 52
LVM index (g/m2.7)41.6 ± 14.9
% LVH26.3
% Actual LVM/Predicted LVM133 ± 36
Actual LVM-predicted LVM (g)37.2 ± 39.2
Aortic PWV (m/sec)6.10 ± 2.76
eGFR (mls/min/1.73m2)94.8 ± 21.7
Resistin (ng/ml)10.5 (range = 1.4 to 83.0)
C-reactive protein (ng/ml)3.64 (range = 0.01 to 71.97)
  1. Continuous data are expressed as mean ± SD or median (range). aMetabolic syndrome is percentage of individuals with 1/2/3/4/5 components of metabolic syndrome. DM diabetes mellitus, SBP systolic blood pressure, DBP diastolic BP, PWV pulse wave velocity, eGFR estimated glomerular filtration rate